Diagnostic value of voiding scores of the "International prostate symptom score" and the "Bristol female lower urinary system symptoms-short form" questionnaires in women with voiding dysfunction

dc.authorscopusid6507444244
dc.authorscopusid58970164700
dc.authorscopusid6701595379
dc.contributor.authorErbay,M.E.
dc.contributor.authorSevinç,B.H.
dc.contributor.authorTarhan,F.
dc.date.accessioned2024-05-25T12:18:55Z
dc.date.available2024-05-25T12:18:55Z
dc.date.issued2024
dc.departmentOkan Universityen_US
dc.department-tempErbay M.E., Department of Urology, Okan University Hospital, University of Health Sciences, Istanbul, Turkey; Sevinç B.H., Clinics of Urology, Maltepe State Hospital, University of Health Sciences, Istanbul, Turkey; Tarhan F., Department of Urology, Kartal Dr. Lütfi Kirdar City Hospital, University of Health Sciences, Istanbul, Turkeyen_US
dc.description.abstractIntroduction: We aimed to investigate the diagnostic value of International Prostate Symptom Score voiding symptom score (IPSS VS) and Bristol Female Lower Urinary Tract Symptoms short form voiding score (BFLUTS VS) in female patients with urodynamically diagnosed voiding dysfunction. Methods: The medical records of female patients who underwent urodynamic examination between May 2007 and November 2021 for lower urinary tract complaints were retrospectively evaluated. A total of 1858 female patients were included in the study. Patients investigated between 2007 and 2014 were asked to fill the IPSS, and patients investigated after 2015 were asked to fill the BFLUTS SF. Results: The mean age of the patients was 49.06 ± 0.33 in the IPSS group and 50.02 ± 0.47 in the BFLUTS group. On the pressure flow study, voiding dysfunction was found in 14.8% (n = 95) in the IPSS group and 15.1% (n = 183) in the BFLUTS group. The area under curve value was found to be 0.58 for IPSS and 0.64 for BFLUTS. Threshold values were found as >9 for IPSS VS and >4 for BFLUTS VS. The sensitivity, specificity, false negative, and false positive rates for IPSS VS were 33.3%, 78.8%, 66.7%, and 21.2%, respectively. The same parameters were 45.5%, 78.9%, 54.5%, and 21.1% for BFLUTS VS, respectively. Conclusion: The diagnostic performance of both the questionnaires was found to be low for diagnosing voiding dysfunction in female patients according to our data. Therefore, the assessment of the voiding phase in women should not solely rely on the current questionnaires. However, further studies using questionnaires including all voiding symptoms are required. © 2024 Indian Journal of Urology.en_US
dc.identifier.citation0
dc.identifier.doi10.4103/iju.iju_162_23
dc.identifier.endpage111en_US
dc.identifier.issn0970-1591
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85189444754
dc.identifier.scopusqualityQ3
dc.identifier.startpage107en_US
dc.identifier.urihttps://doi.org/10.4103/iju.iju_162_23
dc.identifier.urihttps://hdl.handle.net/20.500.14517/1753
dc.identifier.volume40en_US
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofIndian Journal of Urologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keyword Available]en_US
dc.titleDiagnostic value of voiding scores of the "International prostate symptom score" and the "Bristol female lower urinary system symptoms-short form" questionnaires in women with voiding dysfunctionen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files